Anlon Healthcare Ltd vs Multibase India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 23, 2026

Key Highlights

The Latest Trading Price of Anlon Healthcare Ltd is ₹ 121.35 as of 20 Mar 15:30 . The P/E Ratio of Anlon Healthcare Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Multibase India Ltd changed from 35.9 on March 2021 to 23.6 on March 2025 . This represents a CAGR of -8.05% over 5 years The Market Cap of Anlon Healthcare Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Multibase India Ltd changed from ₹ 241.29 crore on March 2021 to ₹ 346.17 crore on March 2025 . This represents a CAGR of 7.49% over 5 years The revenue of Anlon Healthcare Ltd for the Dec '25 is ₹ 35.78 crore as compare to the Sep '25 revenue of ₹ 52.23 crore. This represent the decline of -31.5% The revenue of Multibase India Ltd for the Dec '25 is ₹ 14.37 crore as compare to the Sep '25 revenue of ₹ 19.3 crore. This represent the decline of -25.54% The ebitda of Anlon Healthcare Ltd for the Dec '25 is ₹ 12.54 crore as compare to the Sep '25 ebitda of ₹ 13.77 crore. This represent the decline of -8.93% The ebitda of Multibase India Ltd for the Dec '25 is ₹ 4.7 crore as compare to the Sep '25 ebitda of ₹ 4.15 crore. This represent the growth of 13.25% The net profit of Anlon Healthcare Ltd changed from ₹ 4.54 crore to ₹ 5.15 crore over 7 quarters. This represents a CAGR of 7.47% The net profit of Multibase India Ltd changed from ₹ 3.92 crore to ₹ 3.28 crore over 7 quarters. This represents a CAGR of -9.68% The Dividend Payout of Anlon Healthcare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Multibase India Ltd changed from 37.56 % on March 2021 to 456.56 % on March 2025 . This represents a CAGR of 64.80% over 5 years .

About Anlon Healthcare Ltd

Anlon Healthcare Limited was originally incorporated as 'Anlon Ventures Private Limited', dated November 19, 2013 issued by the RoC. The Company changed the name from 'Anlon Ventures Private Limited' to 'Anlon Healthcare Private Limited' and a fresh Certificate of Incorporation dated May 27, 2015 was issued by the RoC. The status of the Company was subsequently converted to a Public Limited and the name of the Company was changed to 'Anlon Healthcare Limited' dated September 2, 2024 by the RoC. Anlon Healthcare is engaged in manufacturing of Pharma Intermediates and APIs.
They are one of the few manufacturers of loxoprofen sodium dihydrate in India, a notable API , widely used in treatment of pain/inflammation association with conditions including rheumatoid arthritis, osteoarthritis, lower back pain, frozen shoulder, neck-shoulder-arm syndrome, tooth pain or after surgery, injury or tooth extraction.

About Multibase India Ltd

Multibase India Limited was incorporated as Synergy Polymers Limited on 17th December, 1991.
In 1999, the name of Company was changed to Synergy Mulitibase Limited and further to Multibase India Limited on August 31, 2007. Multibase India Ltd is part of the Multibase SA Group, a leading compounder in Europe, the USA and India.
In 2002, the Company was acquired by Multibase SA, subsidiary of Dow Corning Corporation and thus became a Dow corning Company. The company is engaged in in manufacturing, trading and selling of polypropylene compound, thermoplastic elastomer, silicon master batch and thermoplastic master batch.
It is a diverse yet integrated manufacturing company of thermoplastic elastomers and silicone-based products. The Company's products include Silicon-Based Thermoplastics, TPSiV Multiplex, Thermoplastic-Elastomer (TPE physically blends), Triethyl silane (TES) Multiplex Range of Products.

FAQs for the comparison of Anlon Healthcare Ltd and Multibase India Ltd

Which company has a larger market capitalization, Anlon Healthcare Ltd or Multibase India Ltd?

Market cap of Anlon Healthcare Ltd is 644 Cr while Market cap of Multibase India Ltd is 358 Cr

What are the key factors driving the stock performance of Anlon Healthcare Ltd and Multibase India Ltd?

The stock performance of Anlon Healthcare Ltd and Multibase India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Anlon Healthcare Ltd and Multibase India Ltd?

As of March 23, 2026, the Anlon Healthcare Ltd stock price is INR ₹121.35. On the other hand, Multibase India Ltd stock price is INR ₹283.8.

How do dividend payouts of Anlon Healthcare Ltd and Multibase India Ltd compare?

To compare the dividend payouts of Anlon Healthcare Ltd and Multibase India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.